Cargando…

Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments

Nonalcoholic fatty liver disease (NAFLD) is one of the most common chronic liver disorders worldwide. It is associated with clinical states such as obesity, insulin resistance, and type 2 diabetes, and covers a wide range of liver changes, ranging from simple steatosis to non-alcoholic steatohepatit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kitade, Hironori, Chen, Guanliang, Ni, Yinhua, Ota, Tsuguhito
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5409726/ https://www.ncbi.nlm.nih.gov/pubmed/28420094 http://dx.doi.org/10.3390/nu9040387

Ejemplares similares

Roles of Chemokines and Chemokine Receptors in Obesity-Associated Insulin Resistance and Nonalcoholic Fatty Liver Disease
por: Xu, Liang, et al.
Publicado: (2015)

Micronutrient Antioxidants and Nonalcoholic Fatty Liver Disease
por: Chen, Guanliang, et al.
Publicado: (2016)

Hepatic Transcriptome Profiles of Mice with Diet-Induced Nonalcoholic Steatohepatitis Treated with Astaxanthin and Vitamin E
por: Kobori, Masuko, et al.
Publicado: (2017)

Reply to the Letter to the Editor by Li et al.: Bioinformatics Analysis in Mice with Diet-Induced Nonalcoholic Steatohepatitis Treated with Astaxanthin and Vitamin E
por: Kobori, Masuko, et al.
Publicado: (2017)

Novel Action of Carotenoids on Non-Alcoholic Fatty Liver Disease: Macrophage Polarization and Liver Homeostasis
por: Ni, Yinhua, et al.
Publicado: (2016)

Empagliflozin reverses obesity and insulin resistance through fat browning and alternative macrophage activation in mice fed a high-fat diet
por: Xu, Liang, et al.
Publicado: (2019)

SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Mice
por: Xu, Liang, et al.
Publicado: (2017)

Ectopic Fat Accumulation and Distant Organ-Specific Insulin Resistance in Japanese People with Nonalcoholic Fatty Liver Disease
por: Kato, Ken-ichiro, et al.
Publicado: (2014)

Nonalcoholic fatty liver disease: new treatments
por: Hardy, Timothy, et al.
Publicado: (2015)

Obesity-Induced Inflammation and Insulin Resistance
por: Ota, Tsuguhito
Publicado: (2014)

Nonalcoholic fatty liver disease and insulin resistance in children
por: Song, Kyungchul, et al.
Publicado: (2023)

Chemokine Systems Link Obesity to Insulin Resistance
por: Ota, Tsuguhito
Publicado: (2013)

Xanthine oxidase inhibition attenuates insulin resistance and diet-induced steatohepatitis in mice
por: Nishikawa, Tomoki, et al.
Publicado: (2020)

Hypoadiponectinemia and Insulin Resistance are Associated with Nonalcoholic Fatty Liver Disease
por: Yoon, Dokyoung, et al.
Publicado: (2005)

Mechanisms of Insulin Resistance in Primary and Secondary Nonalcoholic Fatty Liver
por: Jelenik, Tomas, et al.
Publicado: (2017)

The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease
por: Fujii, Hideki, et al.
Publicado: (2020)

Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease
por: Armandi, Angelo, et al.
Publicado: (2021)

CCR5: A novel player in the adipose tissue inflammation and insulin resistance?
por: Ota, Tsuguhito
Publicado: (2013)

Astaxanthin prevents and reverses diet-induced insulin resistance and steatohepatitis in mice: A comparison with vitamin E
por: Ni, Yinhua, et al.
Publicado: (2015)

β-Cryptoxanthin Alleviates Diet-Induced Nonalcoholic Steatohepatitis by Suppressing Inflammatory Gene Expression in Mice
por: Kobori, Masuko, et al.
Publicado: (2014)

Nutritional Management of Insulin Resistance in Nonalcoholic Fatty Liver Disease (NAFLD)
por: Conlon, Beth A., et al.
Publicado: (2013)

Pathogenesis of Insulin Resistance and Atherogenic Dyslipidemia in Nonalcoholic Fatty Liver Disease
por: Akhtar, Daud H., et al.
Publicado: (2019)

New Insights of OLFM2 and OLFM4 in Gut-Liver Axis and Their Potential Involvement in Nonalcoholic Fatty Liver Disease
por: Bertran, Laia, et al.
Publicado: (2022)

The Role of Probiotics in Nonalcoholic Fatty Liver Disease: A New Insight into Therapeutic Strategies
por: Meroni, Marica, et al.
Publicado: (2019)

Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver
por: Dongiovanni, P., et al.
Publicado: (2017)

mTOR: A Potential New Target in Nonalcoholic Fatty Liver Disease
por: Feng, Jiayao, et al.
Publicado: (2022)

Insights into Nonalcoholic Fatty-Liver Disease Heterogeneity
por: Arrese, Marco, et al.
Publicado: (2021)

Hepatic Notch Signaling Correlates With Insulin Resistance and Nonalcoholic Fatty Liver Disease
por: Valenti, Luca, et al.
Publicado: (2013)

Tyrosine levels are associated with insulin resistance in patients with nonalcoholic fatty liver disease
por: Kawanaka, Miwa, et al.
Publicado: (2015)

Interleukin‐32 Contributes to Human Nonalcoholic Fatty Liver Disease and Insulin Resistance
por: Dali‐Youcef, Nassim, et al.
Publicado: (2019)

Nonalcoholic Fatty Liver Disease and Thrombocytopenia III: Its Association With Insulin Resistance
por: López-Trujillo, Miguel Antonio, et al.
Publicado: (2019)

A porcine placental extract prevents steatohepatitis by suppressing activation of macrophages and stellate cells in mice
por: Xu, Liang, et al.
Publicado: (2018)

Obeticholic Acid: A New Era in the Treatment of Nonalcoholic Fatty Liver Disease
por: Abenavoli, Ludovico, et al.
Publicado: (2018)

New evidence for the therapeutic potential of curcumin to treat nonalcoholic fatty liver disease in humans
por: Inzaugarat, María Eugenia, et al.
Publicado: (2017)

Subclinical inflammation in relation to insulin resistance in prediabetic subjects with nonalcoholic fatty liver disease
por: Hossain, Israt Ara, et al.
Publicado: (2016)

A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease
por: Chen, Zhonge, et al.
Publicado: (2017)

Hepatocyte Smoothened Activity Controls Susceptibility to Insulin Resistance and Nonalcoholic Fatty Liver Disease
por: Chen, Tianyi, et al.
Publicado: (2022)

Characteristics of hepatic insulin‐sensitive nonalcoholic fatty liver disease
por: Shigiyama, Fumika, et al.
Publicado: (2017)

The Potential Mechanisms of Berberine in the Treatment of Nonalcoholic Fatty Liver Disease
por: Zhu, Xiaopeng, et al.
Publicado: (2016)

Insulin Resistance and Genetic Risk Predict Liver‐Related Outcomes and Death in Nonalcoholic Fatty Liver Disease
por: Danford, Christopher J., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4pekm4js6n16b11g1lauoef2f4